These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 810417)

  • 21. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect.
    Igarashi T; Okada M; Kishimoto S; Yamamura Y
    Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cytotoxic effector potential of some common non-lymphoid tumors and cultured cell lines with phytohemagglutinin and heterologous anti-erythrocyte antisera.
    Muchmore AV; Nelson DL; Blaese RM
    J Immunol; 1975 Mar; 114(3):1001-3. PubMed ID: 803533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of effector cells mediating antitumor activity in spleen cells of tumor-bearing mice.
    Fuyama S; Yamamoto H; Arai S
    Cancer Res; 1985 Sep; 45(9):4103-8. PubMed ID: 3875404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of lymphocyte cytotoxicity by modification of the effector or target cells with periodate or with neuraminidase and galactose oxidase.
    Novogrodsky A
    J Immunol; 1975 Mar; 114(3):1089-93. PubMed ID: 163281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages.
    Jones B; Jones TC
    Immunology; 1978 Feb; 34(2):247-55. PubMed ID: 414994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
    Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
    J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody-dependent cell-mediated cytotoxicity. II. Early interactions between effector and target cells.
    Scornik JC
    J Immunol; 1974 Nov; 113(5):1519-26. PubMed ID: 4418199
    [No Abstract]   [Full Text] [Related]  

  • 28. Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity.
    Cordier G; Samarut C; Revillard JP
    Ann Immunol (Paris); 1981; 132D(1):3-14. PubMed ID: 7347555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two types of antibody dependent cell-mediated cytotoxicity, arming and sensitization.
    Imir T; Saksela E; Mäkelä O
    J Immunol; 1976 Nov; 117(5 Pt.2):1938-42. PubMed ID: 993591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-dependent human lymphocytotoxicity: a micro assay system.
    Zeijlemaker WP; Roos MT; Schellekens PT; Eijsvoogel VP
    Eur J Immunol; 1975 Aug; 5(8):579-84. PubMed ID: 824141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-dependent cell-mediated cytotoxicity: heterogeneity of effector cells in human peripheral blood.
    MacDonald HR; Bonnard GD; Sordat B; Zawodnik SA
    Scand J Immunol; 1975 Sep; 4(5-6):487-97. PubMed ID: 52180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
    Hermann GG; Zeuthen J; Claësson MH
    Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. K cell cytotoxicity against antibody-coated chicken erythrocytes in tumor-bearing mice: its development with progressively growing tumor and the effect of immunization against the tumor.
    Ghaffar A; Calder EA; Irvine WJ
    J Immunol; 1976 Feb; 116(2):315-8. PubMed ID: 1249416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Splenic mediated erythrocyte cytotoxicity in malaria.
    Coleman RM; Rencricca NJ; Stout JP; Brissette WH; Smith DM
    Immunology; 1975 Jul; 29(1):49-54. PubMed ID: 1095474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.